BACKGROUND: Cardiovascular diseases are the major causes of mortality worldwide and acute myocardial infarction (AMI) is the leading cause of mortality among cardiovascular diseases. Thrombolytic therapies, especially during the first few hours after the
Mohammadreza Samieinasab +4 more
doaj
Recent advances in intra-arterial thrombolysis
Thrombolytic therapy has revolutionized acute ischemic stroke (AIS) treatment; however it is clear that intravenous (IV) thrombolytic therapy has certain limitations, including a short-time window for use, poor specificity for the site of arterial ...
Bershad Eric, Suarez Jose
doaj
Objective To investigate the relationship between changes of blood flow of acute middle cerebral artery (MCA) occlusion or stenosis and degree of neural function defect and prognosis before and after intravenous thrombolytic therapy with alteplase ...
Chen ZHOU, Pei-lan ZHANG
doaj
Thrombolytic Therapy in High-Risk Pulmonary Embolism with Thrombocytopenia: Case Report and Literature Review. [PDF]
Boca MI +8 more
europepmc +1 more source
Systemic Inflammation Response Index Predicts Thrombolytic Therapy Requirement in Intermediate-High Risk Acute Pulmonary Embolism: A Retrospective Study. [PDF]
Çiçek T, Yeşildağ K.
europepmc +1 more source
Critical Care After Thrombolytic Therapy in Acute Stroke: Who Really Needs the ICU? [PDF]
Moore KG +6 more
europepmc +1 more source
Direct endovascular therapy with covered stents for the treatment of flush infrarenal aortic occlusion in patients unsuitable for thrombolytic therapy. [PDF]
Peng Y, Deng Y, Chen L, Yu Q, Yuan L.
europepmc +1 more source
Thrombolytic therapy in vertebrobasilar dolichoectasia patients with acute posterior circulation cerebral infarction: a case series analysis. [PDF]
Han Q +6 more
europepmc +1 more source
Intra-arrest systemic thrombolytic therapy during cardiopulmonary resuscitation: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Dehghani S +7 more
europepmc +1 more source

